New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
10:11 EDTXNPTXenoPort urges stockholders to vote for all director nominees
XenoPort announced that it has filed a presentation with the U.S. SEC in connection with the company’s upcoming Annual Meeting, which will be held on June 11. Highlights of the presentation include: XenoPort’s Board of Directors and management team are committed to realizing the full potential of XenoPort’s assets; XenoPort’s Board is active and engaged, and has the depth, diversity of skills and expertise needed to oversee the execution of XenoPort’s strategy; XenoPort is making meaningful progress commercializing and building value in HORIZANT Extended-Release Tablets. With its focused commercial efforts involving just ~40 sales reps, XenoPort recently achieved a level of prescribed HORIZANT tablets, based on the four-week period ending May 9, that corresponds to an annualized gross demand sales run-rate of $25M; XenoPort is committed to optimizing the value of XP23829, and is taking appropriate steps to move it through the development process.
News For XNPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
08:33 EDTXNPTXenoPort announces initiation by NIAAA of clinical trial of AUD treatment
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use